Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126688661 | 12668866 | 1 | I | 20160808 | 20160819 | 20160819 | EXP | BR-PFIZER INC-2016381250 | PFIZER | 81.00 | YR | F | Y | 0.00000 | 20160819 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126688661 | 12668866 | 1 | PS | XALATAN | LATANOPROST | 1 | Ophthalmic | 1 DROP IN THE MORNING AND1 DROP AT NIGHT | U | 20597 | 1 | DF | EYE DROPS, SOLUTION | BID | |||||
| 126688661 | 12668866 | 2 | SS | DRENATAN | LATANOPROST | 1 | UNK | U | 0 | ||||||||||
| 126688661 | 12668866 | 3 | C | AZOPT | BRINZOLAMIDE | 1 | Ophthalmic | 1 DROP IN THE MORNING, 1 DROP AT NIGHT | 0 | 1 | GTT | BID | |||||||
| 126688661 | 12668866 | 4 | C | ENALAPRIL | ENALAPRIL | 1 | Oral | 1 IN THE MORNING, 1 AT NIGHT | 0 | 1 | DF | BID | |||||||
| 126688661 | 12668866 | 5 | C | ROSUVASTATIN CALCIUM. | ROSUVASTATIN CALCIUM | 1 | Oral | 1 TABLET PER DAY | 0 | 1 | DF | TABLET | |||||||
| 126688661 | 12668866 | 6 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 1 TABLET PER DAY | 0 | 1 | DF | TABLET | |||||||
| 126688661 | 12668866 | 7 | C | ALENIA /01479302/ | 2 | 2X/DAY | 0 | BID | |||||||||||
| 126688661 | 12668866 | 8 | C | ALENIA /01479302/ | 2 | 0 | |||||||||||||
| 126688661 | 12668866 | 9 | C | OMEGA 3 /01333901/ | FISH OILTOCOPHEROL | 1 | Oral | 1X/DAY | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126688661 | 12668866 | 1 | Glaucoma |
| 126688661 | 12668866 | 3 | Glaucoma |
| 126688661 | 12668866 | 4 | Hypertension |
| 126688661 | 12668866 | 7 | Asthma |
| 126688661 | 12668866 | 8 | Bronchitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126688661 | 12668866 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126688661 | 12668866 | Blindness unilateral | |
| 126688661 | 12668866 | Blood pressure increased | |
| 126688661 | 12668866 | Cataract | |
| 126688661 | 12668866 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126688661 | 12668866 | 3 | 2015 | 0 | ||
| 126688661 | 12668866 | 4 | 20160802 | 0 | ||
| 126688661 | 12668866 | 5 | 20160802 | 0 | ||
| 126688661 | 12668866 | 6 | 20160802 | 0 | ||
| 126688661 | 12668866 | 7 | 2006 | 0 | ||
| 126688661 | 12668866 | 9 | 2008 | 0 |